Editor-in-chief
The objective of the study was to analyze of developed innovative technologies within the framework of clinical testing in
medical care profiles. To conduct this analysis the clinical testing protocols for 2023 and 2024 from the website of the Ministry of Health
of the Russian Federation were used (https://minzdrav.gov.ru/poleznye-resursy/protokoly-klinicheskoy-aprobatsii/klinicheskoy-aprobatsii). Based on the analysis of the application of the developed innovative technologies within the framework of clinical testing by medical
care profiles for 2023, it was found that the largest number of methods (protocols) were for cardiovascular surgery (38.61%). Based on the
analysis of the distribution of developed innovative technologies within the framework of clinical testing by types (stages of the treatment and diagnostic process) for 2023, it was found that the largest number of methods (protocols) were for treatment methods —
84.16%, which corresponds to 85 methods out of 101 clinical testing methods included in the analysis for 2023. Based on the analysis of
the use of developed innovative technologies within the framework of clinical testing by medical care profiles for 2024, it was found that
the largest number of methods (protocols) were in obstetrics and gynecology — 42.03%, which corresponds to 29 implemented clinical
testing protocols. In 2024, medical care using innovative medical technologies within the framework of clinical testing was mainly provided within the framework of treatment methods in the profiles of obstetrics and gynecology, pediatrics and neonatology in those federal
medical organizations that provide medical care within the framework of clinical testing. Compared to 2023, in 2024 there is a clear emphasis on innovative methods of providing medical care aimed at protecting motherhood and childhood, which is one of the main priorities of the healthcare system of the Russian Federation for the period from 2025 to 2030.
This study discusses ways to improve the risk management system in medical activities using digital technologies. The FMEA method is proposed as the basis, as the most effective from the point of view of assessing the onset, detecting and measuring the consequences of risky events. It is proved that the development of this method of risk assessment based on modern digital solutions makes it possible to form management decisions regarding risks affecting the effectiveness of a medical institution. The purpose of the study is to describe the experience of using digital technologies in risk management in the activities of a federal scientific medical institution.
In our country, the basic organizational approaches to healthcare development, formulated by Nikolai Aleksandrovich Semashko, remain in demand, the implementation of which ensured the sustainability of the public health system and the ability to quickly solve problems at various historical stages. Over the two decades of the XXI century, a basic set of scientifically based ideas about modern requirements for management in medical organizations has been formed and implemented. At the same time, today there is a need to improve the strategy for the development and management of medical organizations in the context of modern socio-economic, geopolitical changes and infectious and epidemiological risks.
In recent years, corporately organized companies have realized the need to manage all forms of relevant knowledge. Such a process involves the creation of knowledge, its collection, sharing and maintenance. The integration of these components in the activities of medical companies is essential to ensure the effectiveness and sustainable development of national health systems. Using this knowledge, practitioners and other employees can make strategic decisions regarding patient treatment, disease prediction and solving operational business tasks.
The objective of the study was to develop an index of innovative readiness of the environment for the implementation of innovative technologies at the level of a healthcare organization. The following materials were used: legislation in the field of healthcare, including compulsory medical insurance: federal laws of the Russian Federation, decrees of the Government of the Russian Federation, orders of the Ministry of Health of Russia, and other methodological materials. Foreign and domestic scientific publications devoted to the implementation of innovative medical technologies in healthcare organizations were also used. Factors and parameters that determine the readiness of the environment of a healthcare organization for the implementation of certain medical technologies were extracted from regulatory legal acts and scientific publications in a structured form. Criteria for a comprehensive analysis of the possibility of implementing an innovative medical technology in a healthcare organization, combined into 8 main blocks, on key aspects of assessing the regional healthcare system in terms of implementing innovations: sufficient qualifications and motivation (interest) of personnel; readiness and interest of the management of the healthcare organization and the founder in implementing the innovative method; sufficient patient population for using the innovative method; availability of practical experience in using analogs of the innovative method in a healthcare organization; availability of the necessary equipment and/or drugs; availability of the necessary buildings and premises; preliminary assessment of the clinical and economic efficiency of implementing an innovative method in a medical organization; sufficiency of tariffs and volumes of medical care for the innovative method and its analogue (comparison method) in a medical organization. The environment of a medical organization is recognized as ready for implementing an innovative medical technology if the total number of points on the checklist is 8 or more points (there must be a «yes» answer to at least one item from each section of the checklist, +1 additional point for one more «yes» answer in any of the sections).
Адрес: 105064, г. Москва, ул. Воронцово Поле, д. 12, стр. 1
Email: r.bulletin@yandex.ru
Телефон: +7 (495) 917-90-41 доп. 143
Кузьмина Юлия Александровна
FSSBI «N.A. Semashko National Research Institute of Public Health»
E-mail: